NCT04007549

Brief Summary

This study will examine the benefits of involving partner in a Screening, Brief Intervention and Referral to Treatment (SBIRT) program for tobacco and alcohol for women treated for breast cancer. Using a two-arm randomized trial (couple brief motivational intervention (CBMI) versus individual brief motivational intervention (IBMI) with repeated measures at 6 weeks, 3 and 6 months.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2019

Longer than P75 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 28, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 5, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2019

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

November 19, 2024

Status Verified

November 1, 2024

Enrollment Period

3 years

First QC Date

June 28, 2019

Last Update Submit

November 15, 2024

Conditions

Keywords

Breast cancerSmoking cessationAlcohol risk reductionCouple interventionScreeningBrief interventionReferral to treatmentRandomized Trial

Outcome Measures

Primary Outcomes (1)

  • Tobacco 7-day point prevalence abstinence (PPA) at 6 months

    6 months

Secondary Outcomes (17)

  • Tobacco 7-day point prevalence abstinence (PPA) at 6 months

    6 weeks

  • Tobacco 7-day point prevalence abstinence (PPA) at 6 months

    3 months

  • Quality of life as per EORTC QLQ-C30

    6 months

  • Quality of life as per EORTC QLQ-C30

    6 weeks

  • Quality of life as per EORTC QLQ-C30

    3 months

  • +12 more secondary outcomes

Study Arms (2)

Individual brief motivational intervention

EXPERIMENTAL

Individual brief motivational intervention (IBMI) on tobacco/alcohol risk reduction for the breast cancer patient; the partner receive e-mail or postal brief advices.

Behavioral: Brief motivational interview on tobacco/alcohol risk reduction

Couple-based brief motivational intervention

ACTIVE COMPARATOR

Couple-based brief motivational intervention (CBMI) on tobacco/alcohol risk reduction.

Behavioral: Brief motivational interview on tobacco/alcohol risk reduction

Interventions

The intervention is a couple brief motivational interview (CBMI) on tobacco/alcohol risk reduction, delivered in a single session and a booster session one month later. It is based on motivational interviewing principals (patient-centered communication, expression of empathy, develops discrepancy, deal with resistance to change, support self-efficacy and autonomy), with feedback on tobacco / alcohol consumption, information delivery and if needed referral to treatment. The intervention also specifically focuses on relational dynamics, and marital support development. This intervention will be compared with a single individual brief motivational intervention (IBMI) and a booster session one month later, only delivered to the patient; and the partner receive e-mail or postal brief advices. All brief interventions will be carried out by the same psychologist trained and supervised for this type of intervention.

Couple-based brief motivational interventionIndividual brief motivational intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • for the breast cancer patient: patients treated for a first breast cancer; Karnofsky Index\> 70;
  • for both patient and partner: ≥18 years old; smoking more than or equal to 1 cigarette/day;
  • without ongoing treatment for current substance-related disorders; having a good understanding of the French language;
  • able to express consent to benefit from intervention focused on smoking cessation;
  • having an email address and internet access at home.

You may not qualify if:

  • Refusal of the patient that his/her partner participates or refusal of the partner to participate
  • Individual deprived of liberty, under guardianship or trusteeship
  • Individual with a dementia or psychiatric disorder that could compromise informed consent and commitment in different times of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut Bergonie

Bordeaux, 33076, France

Location

MeSH Terms

Conditions

Breast NeoplasmsSmoking CessationAlcohol Drinking

Interventions

Ethanol

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesHealth BehaviorBehaviorDrinking Behavior

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Screening, Brief Intervention and Referral to Treatment (SBIRT)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2019

First Posted

July 5, 2019

Study Start

October 1, 2019

Primary Completion

October 1, 2022

Study Completion

October 1, 2025

Last Updated

November 19, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations